ONESOURCE SPECIALTY PHARMA
Back to Balance Sheet
|
ONESOURCE SPECIALTY PHARMA Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Total Current Liabilities | ₹1,114 Cr | ₹631 Cr | ₹865 Cr | ₹809 Cr |
What is the latest Total Current Liabilities ratio of ONESOURCE SPECIALTY PHARMA ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹1,114 Cr |
| Mar2024 | ₹631 Cr |
| Mar2023 | ₹865 Cr |
| Mar2022 | ₹809 Cr |
How is Total Current Liabilities of ONESOURCE SPECIALTY PHARMA Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,114 Cr | 76.59 | |
| Mar2024 | ₹631 Cr | -27.12 | |
| Mar2023 | ₹865 Cr | 6.99 | |
| Mar2022 | ₹809 Cr | - | |
Compare Total Current Liabilities of peers of ONESOURCE SPECIALTY PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ONESOURCE SPECIALTY PHARMA | ₹17,601.9 Cr | -1.1% | -7.2% | -18.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,090.0 Cr | 1% | -2.7% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,976.0 Cr | 0.7% | 17.1% | 40.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,639.0 Cr | -0.3% | -3.7% | 37.9% | Stock Analytics | |
| CIPLA | ₹115,216.0 Cr | -0.3% | 2.3% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | -1.4% | 0.7% | -6.2% | Stock Analytics | |
ONESOURCE SPECIALTY PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ONESOURCE SPECIALTY PHARMA | -1.1% |
-7.2% |
-18.3% |
| SENSEX | -0.6% |
1% |
-3.7% |
You may also like the below Video Courses